Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

NCT06896526 is registered in ClinicalTrials.gov with Precia Group as lead sponsor.

NCT NCT06896526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06896526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry
Lead sponsor
Precia Group
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2025
Completion date
March 31, 2035
Enrollment
10,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

group b streptococcal infection, group b streptococcal infection, early-onset, group b streptococcal infection, late-onset, group b streptococcus, group b streptococcus (gbs) disease, invasive group b streptococcus disease